98%
921
2 minutes
20
Background: Myoclonus dystonia syndrome typically results from autosomal dominant mutations in the epsilon-sarcoglycan gene (SGCE) via the paternally expressed allele on chromosome 7q21. There is evidence that deep brain stimulation (DBS) is beneficial for this genotype, however, there are few prior case reports on DBS for myoclonus dystonia syndrome secondary to other confirmed genetic etiologies.
Case Report: A 20-year-old female with concomitant Russell-Silver syndrome and myoclonus dystonia syndrome secondary to maternal uniparental disomy of chromosome 7 (mUPD7) presented for medically refractory symptoms. She underwent DBS surgery targeting the bilateral globus pallidus interna with positive effects that persisted 16 months post-procedure.
Discussion: We present a patient with the mUPD7 genotype for myoclonus dystonia syndrome who exhibited a similar, if not superior, response to DBS when compared to patients with other genotypes.
Highlights: This report outlines the first described case of successful deep brain stimulation treatment for a rare genetic variant of myoclonus dystonia syndrome caused by uniparental disomy at chromosome 7. These findings may expand treatment options for patients with similar conditions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624206 | PMC |
http://dx.doi.org/10.5334/tohm.782 | DOI Listing |
Int J Mol Sci
August 2025
Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Ul. Zwirki i Wigury 61, 02-091 Warsaw, Poland.
Dystonia-myoclonus syndrome is a rare neurological condition characterized by involuntary muscle contractions and myoclonic jerks, significantly impairing daily functioning. Pharmacological management is often ineffective, prompting consideration of alternative therapeutic interventions such as deep brain stimulation (DBS). This report describes a novel clinical case involving a 38-year-old female with severe dystonic and myoclonic symptoms associated with a pathogenic mutation in the KCNN2 gene (DYT34).
View Article and Find Full Text PDFBackground: Deep brain stimulation of the globus pallidus internus (DBS-GPi) has shown efficacy in adult patients with SGCE-related myoclonus dystonia. However, evidence regarding its impact in pediatric populations is limited.
Objectives: The aim was to evaluate motor and non-motor outcomes following DBS-GPi intervention in children and adolescents with SGCE-MD.
Ethiop J Health Sci
May 2025
Department of Neurosurgery Saint Peter's Specialized Hospital, Addis Ababa Ethiopia.
Background: SGCE myoclonus dystonia is a rare genetic movement disorder caused by mutations in the SGCE gene. It typically presents in childhood and is characterized by myoclonus and dystonia. The inheritance pattern is autosomal dominant with maternal imprinting.
View Article and Find Full Text PDFBrain
July 2025
Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK, CF24 4HQ.
Myoclonus Dystonia is a Mendelian inherited, childhood-onset dystonic disorder, caused by mutations in the autosomal dominantly inherited SGCE gene, and in which both motor and psychiatric phenotypes are observed. Results from murine and in vivo human studies suggest dystonia is caused by disruption to neuronal networks, and in particular the basal ganglia-cerebello-thalamo-cortical circuit. Work focused on the cortical component implicates disruption to neuronal excitatory/inhibitory balance as being a key contributor in the observed phenotypes.
View Article and Find Full Text PDFParkinsonism Relat Disord
September 2025
Expertise Center Movement Disorders Groningen, University Medical Center Groningen (UMCG), Groningen, the Netherlands. Electronic address:
Introduction: The Next Move in Movement Disorders (NEMO) is a cross-sectional study aimed to propose innovative strategies for the classification and management of Hyperkinetic Movement Disorders (HMDs). The clinical visibility of essential tremor, dystonia, cortical myoclonus and myoclonus-dystonia through standardized video procedure is assessed here, with the aim to evaluate the best tasks for eliciting the clinical signs of each specific phenotype.
Methods: Eighty-four patients with HMDs were enrolled: 19 affected by essential tremor, 21 by dystonia, 18 by myoclonus and 26 by myoclonus-dystonia.